Related Experiment Video
Updated: Jun 5, 2026
08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
[Drug-drug interactions and nephrotoxicity]
1Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik, Universitätsklinikum Heidelberg.
Therapeutische Umschau. Revue Therapeutique
|December 25, 2010
Summary
Nephrotoxicity, a common adverse drug reaction, stems from various mechanisms and drug interactions. Prevention strategies include careful drug selection, minimizing exposure, identifying high-risk patients, and considering hydration and prophylactic medications.
Area of Science:
- Pharmacology
- Nephrology
- Drug Safety
Background:
- Nephrotoxicity is a frequent and significant adverse drug reaction.
- It arises from diverse mechanisms including vascular, tubulo-toxic, tubulo-obstructive, and immunological effects.
- Drug-drug interactions, at pharmacokinetic or pharmacodynamic levels, can exacerbate or mitigate nephrotoxicity.
Purpose of the Study:
- To elucidate the mechanisms of drug-induced nephrotoxicity.
- To highlight the role of drug-drug interactions in nephrotoxicity.
- To outline key preventive measures against nephrotoxicity.
Main Methods:
- Review of mechanisms of nephrotoxicity.
- Analysis of pharmacokinetic and pharmacodynamic drug interactions.
- Identification of preventive strategies for drug-induced kidney damage.
Main Results:
- Nephrotoxicity involves vascular, tubular, obstructive, and immune pathways.
- Interactions can increase (e.g., cisplatin, aminoglycoside) or decrease (e.g., cidofovir, probenecid) nephrotoxicity.
- Effective prevention requires considering drug interactions, limiting exposure, risk stratification, and supportive care.
Conclusions:
- Understanding nephrotoxicity mechanisms and drug interactions is crucial for safe prescribing.
- Proactive measures, including patient assessment and prophylactic strategies, are essential for preventing drug-induced kidney injury.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...